. "Pokroky v l\u00E9\u010Db\u011B metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu"@cs . "Kolorekt\u00E1ln\u00ED karcinom pat\u0159\u00ED v \u010Cesk\u00E9 republice k nej\u010Dast\u011Bji se vyskytuj\u00EDc\u00EDm zhoubn\u00FDm n\u00E1dor\u016Fm. I p\u0159es st\u00E1le se zlep\u0161uj\u00EDc\u00ED v\u00FDsledky screeningu byla v roce 2010 t\u00E9m\u011B\u0159 polovina z t\u011Bchto novotvar\u016F diagnostikov\u00E1na v pokro\u010Dil\u00FDch stadi\u00EDch. A\u010Dkoli chirurgick\u00E9 \u0159e\u0161en\u00ED st\u00E1le z\u016Fst\u00E1v\u00E1 z\u00E1kladn\u00ED l\u00E9\u010Debnou modalitou, lze nyn\u00ED vyu\u017Eit\u00EDm modern\u00ED c\u00EDlen\u00E9 l\u00E9\u010Dby v kombinaci s chemoterapi\u00ED dos\u00E1hnout dlouhodob\u00E9 stabilizace onemocn\u011Bn\u00ED, a to i v p\u0159\u00EDpad\u011B pokro\u010Dil\u00E9ho n\u00E1doru, a tak v\u00FDznamn\u011B prodlou\u017Eit \u017Eivot t\u011Bchto pacient\u016F. Krom\u011B p\u0159\u00EDpravk\u016F v praxi ji\u017E b\u011B\u017En\u011B u\u017E\u00EDvan\u00FDch, jako jsou bevacizumab, cetuximab \u010Di panitumumab, se objevuj\u00ED zcela nov\u00E9 l\u00E9ky jako aflibercept \u010Di regorafenib." . "Kiss, Igor" . . . "Kolorekt\u00E1ln\u00ED karcinom pat\u0159\u00ED v \u010Cesk\u00E9 republice k nej\u010Dast\u011Bji se vyskytuj\u00EDc\u00EDm zhoubn\u00FDm n\u00E1dor\u016Fm. I p\u0159es st\u00E1le se zlep\u0161uj\u00EDc\u00ED v\u00FDsledky screeningu byla v roce 2010 t\u00E9m\u011B\u0159 polovina z t\u011Bchto novotvar\u016F diagnostikov\u00E1na v pokro\u010Dil\u00FDch stadi\u00EDch. A\u010Dkoli chirurgick\u00E9 \u0159e\u0161en\u00ED st\u00E1le z\u016Fst\u00E1v\u00E1 z\u00E1kladn\u00ED l\u00E9\u010Debnou modalitou, lze nyn\u00ED vyu\u017Eit\u00EDm modern\u00ED c\u00EDlen\u00E9 l\u00E9\u010Dby v kombinaci s chemoterapi\u00ED dos\u00E1hnout dlouhodob\u00E9 stabilizace onemocn\u011Bn\u00ED, a to i v p\u0159\u00EDpad\u011B pokro\u010Dil\u00E9ho n\u00E1doru, a tak v\u00FDznamn\u011B prodlou\u017Eit \u017Eivot t\u011Bchto pacient\u016F. Krom\u011B p\u0159\u00EDpravk\u016F v praxi ji\u017E b\u011B\u017En\u011B u\u017E\u00EDvan\u00FDch, jako jsou bevacizumab, cetuximab \u010Di panitumumab, se objevuj\u00ED zcela nov\u00E9 l\u00E9ky jako aflibercept \u010Di regorafenib."@cs . "3"^^ . . "5"^^ . . . "Remedia" . . "96896" . "Advances in the treatment of metastatic colorectal cancer"@en . "CZ - \u010Cesk\u00E1 republika" . "[D790519D6BA2]" . "http://www.remedia.cz/Archiv-rocniku/Rocnik-2013/6-2013/Pokroky-v-lecbe-metastatickeho-kolorektalniho-karcinomu/e-1pe-1z2-1Ad.magarticle.aspx" . "3"^^ . . . "Advances in the treatment of metastatic colorectal cancer"@en . "colorectal cancer; targeted therapy; bevacizumab; cetuximab; panitumumab; aflibercept; regorafenib"@en . . . . "RIV/00209805:_____/13:#0000489!RIV14-MZ0-00209805" . . . "23" . "RIV/00209805:_____/13:#0000489" . "0862-8947" . "Pokroky v l\u00E9\u010Db\u011B metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu" . . . "Hal\u00E1mkov\u00E1, Jana" . . "Pokroky v l\u00E9\u010Db\u011B metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu"@cs . "Pokroky v l\u00E9\u010Db\u011B metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu" . . . . "I" . "Colorectal cancer is one of the Czech Republic, the most frequent malignant tumors. Despite continuously improving screening in 2010 was almost half of these tumors are diagnosed in advanced stages. Although surgical treatment still remains the main treatment modality, can now experience the modern targeted therapy in combination with chemotherapy to achieve long-term disease stabilization, even in cases of advanced cancer, and thus significantly extend the life of these patients. In addition to the products already in practice commonly used, such as bevacizumab, cetuximab or panitumumab, appear completely new drugs such as aflibercept or regorafenib."@en . "Tom\u00E1\u0161ek, Ji\u0159\u00ED" . . "6" .